Reuters - Israel's Teva Pharmaceutical Industries Ltd raised its 2007 earnings outlook following the launch of its generic version of Wyeth's ulcer drug Protonix.
TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries Ltd raised its 2007 earnings outlook following the launch of its generic version of Wyeth's ulcer drug Protonix.